In this review, we will discuss multidisciplinary considerations in treating patients with neoadjuvant therapy and highlight areas of controversy and ongoing research.
Susan Harvey, MD
Advertisement
Articles by Susan Harvey, MD
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
FDA Approves Relacorilant Combo in Platinum-Resistant Ovarian Cancers
2
Bevacizumab Biosimilar Shows Clinical Equivalence in Advanced NSCLC
3
Neoadjuvant Strategies and Early Biomarker Testing in EGFR-Mutated NSCLC
4
Nadofaragene Firadenovec Label Update Approved in BCG-Unresponsive NMIBC
5